$FCUV
FOCUS UNIVERSAL INC. Stock $fcuv

$fcuv Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000168316824005592 Filed on August 14, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue	$74.22K	$19.75K
YoY Change	-76.69%	-90.83%
Cost Of Revenue	$42.53K	$31.83K
YoY Change	-78.88%	-78.67%
Gross Profit	$31.69K	-$12.08K
YoY Change	-72.91%	-118.27%
Gross Profit Margin	42.69%	-61.16%
Selling, General & Admin	$616.4K	$661.1K
YoY Change	39.63%	55.69%
% of Gross Profit	1945.49%
Research & Development	$308.5K	$296.2K
YoY Change	0.86%	-13.63%
% of Gross Profit	973.7%
Depreciation & Amortization	$5.390K	$32.02K
YoY Change	-87.67%	-24.8%
% of Gross Profit	17.01%
Operating Expenses	$1.779M	$1.367M
YoY Change	55.02%	20.17%
Operating Profit	-$1.747M	-$1.379M
YoY Change	69.55%	28.71%
Interest Expense	$13.46K	-$73.68K
YoY Change	-270.38%	-726.0%
% of Operating Profit
Other Income/Expense, Net	$3.216M	$14.03K
YoY Change	5064.23%	-73.69%
Pretax Income	$1.469M	-$1.365M
YoY Change	-251.72%	34.08%
Income Tax
% Of Pretax Income
Net Earnings	$1.442M	-$1.365M
YoY Change	-248.95%	34.07%
Net Earnings / Revenue	1942.91%	-6910.88%
Basic Earnings Per Share	$0.02	-$0.02
Diluted Earnings Per Share	$0.02	-$0.02
COMMON SHARES
Basic Shares Outstanding	64.87M shares	64.77M shares
Diluted Shares Outstanding	65.72M shares	64.84M shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.395M	$40.64K
YoY Change	272.64%	-97.14%
Cash & Equivalents	$5.368M	$13.06K
Short-Term Investments	$27.04K	$27.58K
Other Short-Term Assets	$124.4K	$97.97K
YoY Change	13.16%	-47.67%
Inventory	$478.8K	$495.9K
Prepaid Expenses	$124.4K	$97.97K
Receivables	$0.00	$19.78K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$5.972M	$654.3K
YoY Change	192.62%	-63.57%
LONG-TERM ASSETS
Property, Plant & Equipment	$57.43K	$4.022M
YoY Change	-98.61%	-3.3%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$65.81K	$25.71K
YoY Change	181.0%	9.17%
Total Long-Term Assets	$258.9K	$4.201M
YoY Change	-94.06%	-4.94%
TOTAL ASSETS
Total Short-Term Assets	$5.972M	$654.3K
Total Long-Term Assets	$258.9K	$4.201M
Total Assets	$6.230M	$4.855M
YoY Change	-2.63%	-21.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$550.0K	$1.061M
YoY Change	92.85%	247.48%
Accrued Expenses	$107.0K	$99.57K
YoY Change	27.36%	22.62%
Deferred Revenue
YoY Change
Short-Term Debt	$75.00K	$225.0K
YoY Change	-92.5%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$763.9K	$3.664M
YoY Change	-45.8%	747.81%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Total Long-Term Liabilities	$20.84K	$31.80K
YoY Change	-84.59%	-77.9%
TOTAL LIABILITIES
Total Short-Term Liabilities	$763.9K	$3.664M
Total Long-Term Liabilities	$20.84K	$31.80K
Total Liabilities	$784.8K	$3.696M
YoY Change	-49.2%	541.53%
SHAREHOLDERS EQUITY
Retained Earnings	-$23.82M	-$25.26M
YoY Change	13.63%	26.34%
Common Stock	$72.92K	$64.87K
YoY Change	12.58%	0.15%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$5.446M	$1.160M
YoY Change
Total Liabilities & Shareholders Equity	$6.230M	$4.855M
YoY Change	-2.63%	-21.88%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	$1.442M	-$1.365M
YoY Change	-248.95%	34.07%
Depreciation, Depletion And Amortization	$5.390K	$32.02K
YoY Change	-87.67%	-24.8%
Cash From Operating Activities	-$1.937M	-$829.9K
YoY Change	94.95%	8.03%
INVESTING ACTIVITIES
Capital Expenditures	$3.510K	$4.700K
YoY Change	1110.34%	-35.44%
Acquisitions
YoY Change
Other Investing Activities	$7.146M	$0.00
YoY Change	48280.57%	-100.0%
Cash From Investing Activities	$7.142M	-$4.700K
YoY Change	49259.36%	-77.54%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	125.0K	776.0K
YoY Change	-87.91%	-284.46%
NET CHANGE
Cash From Operating Activities	-1.937M	-829.9K
Cash From Investing Activities	7.142M	-4.700K
Cash From Financing Activities	125.0K	776.0K
Net Change In Cash	5.330M	-58.56K
YoY Change	9551.19%	-95.16%
FREE CASH FLOW
Cash From Operating Activities	-$1.937M	-$829.9K
Capital Expenditures	$3.510K	$4.700K
Free Cash Flow	-$1.940M	-$834.6K
YoY Change	95.25%	7.62%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q2	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend		usd
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-3355876
	dei	Entity Address Address Line1 EntityAddressAddressLine1	2311 E. Locust Court
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1018166	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	5639341	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	5639341	usd
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-55247
	dei	Entity Registrant Name EntityRegistrantName	FOCUS UNIVERSAL INC.
	dei	Entity Address City Or Town EntityAddressCityOrTown	Ontario
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	91761
	dei	City Area Code CityAreaCode	626
	dei	Local Phone Number LocalPhoneNumber	272-3883
	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value
	dei	Trading Symbol TradingSymbol	FCUV
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	64867760	shares
CY2023Q4	us-gaap	Cash Cash	428254	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	164398	usd
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	20519	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	96301	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	654329	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	1028278	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4022095	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4080663	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	153061	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	201048	usd
CY2024Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	25713	usd
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	24135	usd
CY2024Q2	us-gaap	Assets Assets	4855198	usd
CY2023Q4	us-gaap	Assets Assets	5334124	usd
CY2024Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1061029	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	482523	usd
CY2024Q2	FCUV	Related Party Loan RelatedPartyLoan	2101000	usd
CY2023Q4	FCUV	Related Party Loan RelatedPartyLoan	1000000	usd
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	0	usd
CY2024Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	177142	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	84951	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	99570	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	90172	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	3663741	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1657646	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	31802	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	118517	usd
CY2024Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	0	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	12335	usd
CY2024Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	31802	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	130852	usd
CY2024Q2	us-gaap	Liabilities Liabilities	3695543	usd
CY2023Q4	us-gaap	Liabilities Liabilities	1788498	usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	64867760	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	64867760	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	64771817	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	64771817	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	64867	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	64771	usd
CY2024Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	1133040	shares
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	1163040	shares
CY2024Q2	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	385686	usd
CY2023Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	434048	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	26749219	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	26436161	usd
CY2024Q2	FCUV	Shares To Be Issued Common Shares Value SharesToBeIssuedCommonSharesValue	15968	usd
CY2023Q4	FCUV	Shares To Be Issued Common Shares Value SharesToBeIssuedCommonSharesValue	74476	usd
CY2024Q2	us-gaap	Treasury Stock Retired Cost Method Amount TreasuryStockRetiredCostMethodAmount		usd
	us-gaap	Treasury Stock Retired Cost Method Amount TreasuryStockRetiredCostMethodAmount		usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
	us-gaap	Treasury Stock Retired Cost Method Amount TreasuryStockRetiredCostMethodAmount		usd
	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend		usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	282071	usd
CY2023Q4	us-gaap	Marketable Securities MarketableSecurities	36735	usd
CY2024Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	225000	usd
CY2024Q2	us-gaap	Common Stock Shares Subscribed But Unissued CommonStockSharesSubscribedButUnissued	25197	shares
CY2023Q4	us-gaap	Common Stock Shares Subscribed But Unissued CommonStockSharesSubscribedButUnissued	41463	shares
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-25262873	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-22582170	usd
CY2024Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-21840	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-13564	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	1159655	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	3545626	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4855198	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5334124	usd
CY2024Q2	us-gaap	Revenues Revenues	19753	usd
CY2023Q2	us-gaap	Revenues Revenues	215391	usd
CY2024Q2	us-gaap	Cost Of Revenue CostOfRevenue	31834	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	149259	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	-12081	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	66132	usd
CY2024Q2	us-gaap	Selling Expense SellingExpense	35640	usd
CY2023Q2	us-gaap	Selling Expense SellingExpense	63075	usd
CY2024Q2	us-gaap	Officers Compensation OfficersCompensation	55255	usd
CY2023Q2	us-gaap	Officers Compensation OfficersCompensation	253403	usd
CY2024Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	296248	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	342992	usd
CY2024Q2	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	354421	usd
CY2023Q2	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	116565	usd
CY2024Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	625492	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	361583	usd
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	1367056	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	1137618	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1379137	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1071486	usd
CY2024Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-9900	usd
CY2023Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	16118	usd
CY2024Q2	FCUV	Interest Expense Related Party1 InterestExpenseRelatedParty1	56098	usd
CY2023Q2	FCUV	Interest Expense Related Party1 InterestExpenseRelatedParty1	-0	usd
CY2024Q2	FCUV	Gain On Bargain Purchase GainOnBargainPurchase	0	usd
CY2023Q2	FCUV	Gain On Bargain Purchase GainOnBargainPurchase	0	usd
	FCUV	Gain On Bargain Purchase GainOnBargainPurchase	0	usd
	FCUV	Gain On Bargain Purchase GainOnBargainPurchase	61747	usd
CY2024Q2	us-gaap	Debt And Equity Securities Unrealized Gain Loss DebtAndEquitySecuritiesUnrealizedGainLoss	-7680	usd
CY2023Q2	us-gaap	Debt And Equity Securities Unrealized Gain Loss DebtAndEquitySecuritiesUnrealizedGainLoss	-5005	usd
	us-gaap	Debt And Equity Securities Unrealized Gain Loss DebtAndEquitySecuritiesUnrealizedGainLoss	-9155	usd
	us-gaap	Debt And Equity Securities Unrealized Gain Loss DebtAndEquitySecuritiesUnrealizedGainLoss	27565	usd
CY2024Q2	us-gaap	Debt Securities Realized Gain Loss DebtSecuritiesRealizedGainLoss	0	usd
CY2023Q2	us-gaap	Debt Securities Realized Gain Loss DebtSecuritiesRealizedGainLoss	652	usd
	us-gaap	Debt Securities Realized Gain Loss DebtSecuritiesRealizedGainLoss	0	usd
	us-gaap	Debt Securities Realized Gain Loss DebtSecuritiesRealizedGainLoss	-14249	usd
CY2024Q2	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	41547	usd
CY2023Q2	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	40341	usd
	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	82692	usd
	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	80293	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	46162	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1214	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	44958	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5859	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	14031	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	53320	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	18244	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	180051	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-1365106	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1018166	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2680703	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2132409	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	7287	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	3883	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	8276	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	208	usd
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1372393	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1022049	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2688979	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2132617	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	64837385	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	64837385	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	65171740	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	65171740	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	64804420	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	64804420	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55377422	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	55377422	shares
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	2360945	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	2360945	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	36995	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	134108	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-7287	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-1365106	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	1159655	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	1159655	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	6929773	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	6929773	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	133403	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	18900	usd
CY2023Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	420686	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-3883	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	3545626	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	3545626	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	73990	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	229018	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-8276	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2680703	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	1159655	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	1159655	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	7757534	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	7757534	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	266806	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	168304	usd
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	420686	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-208	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2132409	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	5639341	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	5639341	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2680703	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2132409	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	60570	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	4675	usd
	us-gaap	Depreciation Depreciation	67354	usd
	us-gaap	Depreciation Depreciation	84616	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	28741	usd
	us-gaap	Debt And Equity Securities Unrealized Gain Loss DebtAndEquitySecuritiesUnrealizedGainLoss	-9155	usd
	us-gaap	Debt And Equity Securities Unrealized Gain Loss DebtAndEquitySecuritiesUnrealizedGainLoss	27565	usd
	us-gaap	Debt Securities Realized Gain Loss DebtSecuritiesRealizedGainLoss	-0	usd
	us-gaap	Debt Securities Realized Gain Loss DebtSecuritiesRealizedGainLoss	-14249	usd
	FCUV	Gain On Bargain Purchase GainOnBargainPurchase	-0	usd
	FCUV	Gain On Bargain Purchase GainOnBargainPurchase	61747	usd
	FCUV	Share Based Compensation Shares Value ShareBasedCompensationSharesValue	229018	usd
	FCUV	Share Based Compensation Shares Value ShareBasedCompensationSharesValue	168304	usd
	FCUV	Share Based Compensation Options Value ShareBasedCompensationOptionsValue	73990	usd
	FCUV	Share Based Compensation Options Value ShareBasedCompensationOptionsValue	266806	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-84053	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	27741	usd
	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	-0	usd
	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	-34507	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	213873	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-15526	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-20394	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-0	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	1833	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	46109	usd
	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	2223	usd
	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-8514	usd
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	42985	usd
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	4983	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	581696	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	73823	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	92191	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	39100	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-72385	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-55012	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-12335	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	0	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1721946	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1606739	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	9743	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	17203	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	-0	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	43644	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	101736	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-9743	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	40889	usd
	FCUV	Proceeds From Third Party Loan ProceedsFromThirdPartyLoan	350000	usd
	FCUV	Proceeds From Third Party Loan ProceedsFromThirdPartyLoan	0	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	1101000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	usd
	FCUV	Repayment On Third Party Loan RepaymentOnThirdPartyLoan	125000	usd
	FCUV	Repayment On Third Party Loan RepaymentOnThirdPartyLoan	-0	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	-0	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1420686	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1326000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1420686	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-9501	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1793	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-415190	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2984743	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	428254	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4343426	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13064	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1358683	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	us-gaap	Interest Paid Net InterestPaidNet	57218	usd
	us-gaap	Interest Paid Net InterestPaidNet	8407	usd
	FCUV	Right Of Use Asset Obtained In Exchange For Operating Lease Liability1 RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability1	0	usd
	FCUV	Right Of Use Asset Obtained In Exchange For Operating Lease Liability1 RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability1	266101	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84B_eus-gaap--UseOfEstimates_zxLsvSKbnI5k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_862_zI3LiV4RDrIf">Use of Estimates</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the date of the accompanying unaudited condensed consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. Significant estimates in the accompanying financial statements include the lease term impacting right-of use asset and lease liability, useful lives of property and equipment, allowance for doubtful accounts, inventory reserves, and the valuation allowance on deferred tax assets. The Company regularly evaluates its estimates and assumptions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	262543	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	249603	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_840_eus-gaap--ConcentrationRiskCreditRisk_zUuD4xeja4s3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_869_z1iS7ByVfEeb">Concentrations of Credit and Business Risk</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents. The Company limits its exposure to credit loss by investing its cash with high credit quality financial institutions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-decoration: underline">Major customers</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the three months ended of June 30, 2024 and 2023, the Company’s revenue received from the following companies were set out as below:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zhUkwrB9us7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details - Concentration of risk)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B5_zR6pVq6sOFsc"><b style="display: none">Concentration of risk</b></span></td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three months ended June 30,</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">% of Total <br/> Revenue</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">% of Total <br/> Revenue</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; width: 36%">Customer A</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span id="xdx_909_eus-gaap--Revenues_c20240401__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zIZHCUv07Rrb" title="Revenue">12,750</span></td><td style="width: 1%; text-align: left"> </td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20240401__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zWlC5XOdn1Te" title="Concentration risk percentage">65</span>%</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span style="font-size: 10pt">()</span></td><td style="width: 1%; text-align: left"> </td> <td style="width: 2%"> </td> <td style="text-align: right; width: 1%"> </td> <td style="text-align: right; width: 12%">()</td><td style="width: 1%"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Customer B</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_eus-gaap--Revenues_c20240401__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zFUzp4GsEZRf" title="Revenue">6,000</span></td><td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20240401__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zgRWo6J2ggg" title="Concentration risk percentage">30</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-size: 10pt">()</span></td><td style="text-align: left"> </td> <td> </td> <td style="text-align: right"> </td> <td style="text-align: right">()</td><td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Customer C</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-size: 10pt">()</span></td><td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-size: 10pt">()</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--Revenues_c20230401__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zvZbyR0mvJUb" title="Revenue">105,000</span></td><td style="text-align: left"> </td> <td> </td> <td style="text-align: right"> </td> <td style="text-align: right"><span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20230401__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zVpmMz5c13Xe" title="Concentration risk percentage">49</span>%</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Customer D</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-size: 10pt">()</span></td><td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-size: 10pt">()</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--Revenues_c20230401__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember_zPPRwGLrhfZ9" title="Revenue">38,253</span></td><td style="text-align: left"> </td> <td> </td> <td style="text-align: right"> </td> <td style="text-align: right"><span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_c20230401__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember_zsj7JmEIvTqe" title="Concentration risk percentage">18</span>%</td> <td> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">_________________</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 9%"> </td> <td style="width: 6%"><span style="font-size: 10pt">()</span></td> <td style="width: 85%; text-align: justify"><span style="font-size: 10pt">Revenue had not exceeded 10% or more of the Company’s consolidated revenue of the Company.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="14" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Six months ended June 30,</b></span></td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>2024</b></span></td> <td> </td> <td> </td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>2023</b></span></td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap"> </td> <td colspan="2" style="border-bottom: black 1pt solid; white-space: nowrap; text-align: center"><span style="font-size: 10pt"><b>Amount</b></span></td> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap"> </td> <td colspan="2" style="border-bottom: black 1pt solid; white-space: nowrap; text-align: center"><span style="font-size: 10pt"><b>% of Total <br/> Revenue</b></span></td> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap"> </td> <td colspan="2" style="border-bottom: black 1pt solid; white-space: nowrap; text-align: center"><span style="font-size: 10pt"><b>Amount</b></span></td> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap"> </td> <td colspan="2" style="border-bottom: black 1pt solid; white-space: nowrap; text-align: center"><span style="font-size: 10pt"><b>% of Total <br/> Revenue</b></span></td> <td style="white-space: nowrap; text-align: justify"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 36%; text-align: justify"><span style="font-size: 10pt">Customer F</span></td> <td style="width: 2%; text-align: justify"> </td> <td style="width: 1%; text-align: justify"><span style="font-size: 10pt">$</span></td> <td style="width: 12%; text-align: right"><span style="font-size: 10pt"><span id="xdx_909_eus-gaap--Revenues_c20240101__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerFMember_ztvi7Hxb3W84" title="Revenue">69,325</span></span></td> <td style="width: 1%; text-align: justify"> </td> <td style="width: 2%; text-align: justify"> </td> <td style="width: 1%; text-align: justify"> </td> <td style="width: 12%; text-align: right"><span style="font-size: 10pt"><span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20240101__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerFMember_zqR8GGUEHA96" title="Concentration risk percentage">29</span>%</span></td> <td style="width: 1%; text-align: justify"><span style="font-size: 10pt"> </span></td> <td style="width: 2%; text-align: justify"> </td> <td style="width: 1%; text-align: justify"><span style="font-size: 10pt">$</span></td> <td style="width: 12%; text-align: right"><span style="font-size: 10pt">()</span></td> <td style="width: 1%; text-align: justify"><span style="font-size: 10pt"> </span></td> <td style="width: 2%; text-align: justify"> </td> <td style="width: 1%; text-align: justify"> </td> <td style="width: 12%; text-align: right"><span style="font-size: 10pt">()</span></td> <td style="width: 1%; text-align: justify"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-size: 10pt">Customer G</span></td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_903_eus-gaap--Revenues_c20240101__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerGMember_zcLiNKS5rj3c" title="Revenue">51,761</span></span></td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20240101__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerGMember_zG1Fd7tfjqbi" title="Concentration risk percentage">22</span>%</span></td> <td style="text-align: justify"><span style="font-size: 10pt"> </span></td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: right"><span style="font-size: 10pt">()</span></td> <td><span style="font-size: 10pt"> </span></td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: right"><span style="font-size: 10pt">()</span></td> <td style="text-align: justify"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify"><span style="font-size: 10pt">Customer H</span></td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_90E_eus-gaap--Revenues_c20240101__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerHMember_zxb4CZKKpNP6" title="Revenue">34,492</span></span></td> <td> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20240101__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerHMember_z7WgEtS1VjTi" title="Concentration risk percentage">14</span>%</span></td> <td style="text-align: justify"><span style="font-size: 10pt"> </span></td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: right"><span style="font-size: 10pt">()</span></td> <td style="text-align: justify"><span style="font-size: 10pt"> </span></td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: right"><span style="font-size: 10pt">()</span></td> <td style="text-align: justify"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-size: 10pt">Customer C</span></td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: right"><span style="font-size: 10pt">()</span></td> <td style="text-align: justify"><span style="font-size: 10pt"> </span></td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: right"><span style="font-size: 10pt">()</span></td> <td style="text-align: justify"><span style="font-size: 10pt"> </span></td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_905_eus-gaap--Revenues_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zP8uElI6xWbj" title="Revenue">105,000</span></span></td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zwwgwERTGyS2" title="Concentration risk percentage">23</span>%</span></td> <td style="text-align: justify"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify"><span style="font-size: 10pt">Customer D</span></td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: right"><span style="font-size: 10pt">()</span></td> <td style="text-align: justify"><span style="font-size: 10pt"> </span></td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: right"><span style="font-size: 10pt">()</span></td> <td style="text-align: justify"><span style="font-size: 10pt"> </span></td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_90E_eus-gaap--Revenues_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember_zSf4Z3ETytD" title="Revenue">63,711</span></span></td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember_zETKibK9o8Ok" title="Concentration risk percentage">7</span>%</span></td> <td style="text-align: justify"><span style="font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">_________________</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 81px"> </td> <td style="width: 54px"><span style="font-size: 10pt">()</span></td> <td style="text-align: justify"><span style="font-size: 10pt">Revenue had not exceeded 10% or more of the Company’s consolidated revenue of the Company.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td> </td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>June 30, 2024</b></span></td> <td> </td> <td> </td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>December 31, 2023</b></span></td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: justify"> </td> <td style="white-space: nowrap"> </td> <td colspan="2" style="border-bottom: black 1pt solid; white-space: nowrap; text-align: center"><span style="font-size: 10pt"><b>Amount</b></span></td> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap"> </td> <td colspan="2" style="border-bottom: black 1pt solid; white-space: nowrap; text-align: center"><span style="font-size: 10pt"><b>% of Total <br/> Accounts <br/> Receivable</b></span></td> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap"> </td> <td colspan="2" style="border-bottom: black 1pt solid; white-space: nowrap; text-align: center"><span style="font-size: 10pt"><b>Amount</b></span></td> <td style="text-align: left; white-space: nowrap"> </td> <td style="white-space: nowrap"> </td> <td colspan="2" style="border-bottom: black 1pt solid; white-space: nowrap; text-align: center"><span style="font-size: 10pt"><b>% of Total <br/> Accounts <br/> Receivable</b></span></td> <td style="white-space: nowrap; text-align: justify"> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 36%; text-align: justify"><span style="font-size: 10pt">Customer G</span></td> <td style="width: 2%; text-align: justify"> </td> <td style="width: 1%; text-align: justify"><span style="font-size: 10pt">$</span></td> <td style="width: 12%; text-align: right"><span style="font-size: 10pt"><span id="xdx_904_eus-gaap--AccountsReceivableNet_iI_c20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerGMember_zYGdoNAJEM2b" title="Accounts receivable">12,941</span></span></td> <td style="width: 1%; text-align: justify"> </td> <td style="width: 2%; text-align: justify"> </td> <td style="width: 1%; text-align: justify"> </td> <td style="width: 12%; text-align: right"><span style="font-size: 10pt"><span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20240101__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerGMember_zJp01Gesmy4" title="Concentration risk percentage">65</span>%</span></td> <td style="width: 1%; text-align: justify"><span style="font-size: 10pt"> </span></td> <td style="width: 2%; text-align: justify"> </td> <td style="width: 1%; text-align: justify"><span style="font-size: 10pt">$</span></td> <td style="width: 12%; text-align: right"><span style="font-size: 10pt">()</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td> <td style="width: 2%; text-align: right"> </td> <td style="width: 1%; text-align: right"> </td> <td style="width: 12%; text-align: right"><span style="font-size: 10pt">()</span></td> <td style="width: 1%; text-align: justify"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><span style="font-size: 10pt">Customer I</span></td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_90D_eus-gaap--AccountsReceivableNet_iI_c20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerIMember_ziQHP5K86oTd" title="Accounts receivable">3,584</span></span></td> <td> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_c20240101__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerIMember_znh5YdMit8p9" title="Concentration risk percentage">19</span>%</span></td> <td style="text-align: justify"><span style="font-size: 10pt"> </span></td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: right"><span style="font-size: 10pt">()</span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"><span style="font-size: 10pt">()</span></td> <td style="text-align: justify"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="text-align: justify"><span style="font-size: 10pt">Customer B</span></td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_903_eus-gaap--AccountsReceivableNet_iI_c20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_z8UBb0qRvk56" title="Accounts receivable">3,250</span></span></td> <td> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_c20240101__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zKnDp4EdKnJ2" title="Concentration risk percentage">16</span>%</span></td> <td style="text-align: justify"><span style="font-size: 10pt"> </span></td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: right"><span style="font-size: 10pt">()</span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"><span style="font-size: 10pt">()</span></td> <td style="text-align: justify"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><span style="font-size: 10pt">Customer C</span></td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: right"><span style="font-size: 10pt">()</span></td> <td><span style="font-size: 10pt"> </span></td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: right"><span style="font-size: 10pt">()</span></td> <td style="text-align: justify"><span style="font-size: 10pt"> </span></td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_903_eus-gaap--AccountsReceivableNet_iI_c20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zs8J9MYQx81l" title="Accounts receivable">70,000</span></span></td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zNGIYYChcWP2" title="Concentration risk percentage">43</span>%</span></td> <td style="text-align: justify"><span style="font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">_________________</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 88px"> </td> <td style="width: 59px"><span style="font-size: 10pt">(*)</span></td> <td style="text-align: justify"><span style="font-size: 10pt">Accounts receivable had not exceeded 10% or more of the Company’s consolidated accounts receivable of the Company.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-decoration: underline">Major vendors</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No major vendor accounted more than 10% of total purchase during six months ended June 30, 2024 and 2023.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_845_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zZbM7MUXbno3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_86A_zUggUqTGErme">Share-based Compensation</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for stock-based compensation to employees in conformity with the provisions of ASC Topic 718, Stock-Based Compensation. Stock-based compensation to employees consist of stock options, grants, and restricted shares that are recognized in the statement of operations based on their fair values at the date of grant.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The measurement of stock-based compensation is subject to periodic adjustments as the underlying equity instruments vest and is recognized as an expense over the period during which services are received.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company calculates the fair value of option grants utilizing the Black-Scholes pricing model and estimates the fair value of the stock based upon the estimated fair value of the common stock. The amount of stock-based compensation recognized during a period is based on the value of the portion of the awards that are ultimately expected to vest.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The resulting stock-based compensation expense for both employee and non-employee awards is generally recognized on a straight- line basis over the requisite service period of the award.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p id="xdx_84C_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z361uqhkA3Vi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_86A_zYJ6c7tDb593">Fair Value of Financial Instruments</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company follows paragraph ASC 825-10-50-10 for disclosures about fair value of its financial instruments and paragraph ASC 820-10-35-37 (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in accounting principles generally accepted in the United States of America (U.S. GAAP), and expands disclosures about fair value measurements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three (3) broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three (3) levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1: Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2: Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3: Pricing inputs that are generally unobservable inputs and not corroborated by market data.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table summarize financial assets and liabilities measured at fair value on a recurring basis as of June 30, 2024 and December 31, 2023:</p> <table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_zJ7K4ZMutfJf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details-Fair value recurring basis)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B3_zkYSpNxQeatc" style="display: none">Schedule of financial assets and liabilities measured at fair value</span></td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="14" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2024 (unaudited)</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center">Fair Value</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Carrying</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 1</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 2</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 3</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Value</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Assets</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Marketable securities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 40%; padding-bottom: 1pt; padding-left: 10pt">Stock</td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--FairValueNetAssetLiability_iI_pp0p0_c20240630__us-gaap--FinancialInstrumentAxis__custom--MarketableSecuritiesStockMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zv5Lfq0CeICf" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Total assets measured at fair value">27,580</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--FairValueNetAssetLiability_iI_pp0p0_d0_c20240630__us-gaap--FinancialInstrumentAxis__custom--MarketableSecuritiesStockMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zQb5DTjmp1D6" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Total assets measured at fair value">–</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--FairValueNetAssetLiability_iI_pp0p0_d0_c20240630__us-gaap--FinancialInstrumentAxis__custom--MarketableSecuritiesStockMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z2k2vwIPQV72" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Total assets measured at fair value">–</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--FairValueNetAssetLiability_iI_pp0p0_c20240630__us-gaap--FinancialInstrumentAxis__custom--MarketableSecuritiesStockMember_zUBcXmF1hrE9" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Total assets measured at fair value">27,580</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Total assets measured at fair value</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--FairValueNetAssetLiability_iI_pp0p0_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zbPgppKJRhs1" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets measured at fair value">27,580</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--FairValueNetAssetLiability_iI_pp0p0_d0_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zGhsSUYfCc2i" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets measured at fair value">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--FairValueNetAssetLiability_iI_pp0p0_d0_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z44gjEiqtTlb" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets measured at fair value">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--FairValueNetAssetLiability_iI_pp0p0_c20240630_zIfafUdvyh1e" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets measured at fair value">27,580</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="14" style="border-bottom: Black 1pt solid; text-align: center">December 31, 2023</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center">Fair Value</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Carrying</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 1</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 2</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 3</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Value</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Assets</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Marketable securities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 40%; padding-bottom: 1pt; padding-left: 10pt">Stock</td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--FairValueNetAssetLiability_iI_pp0p0_c20231231__us-gaap--FinancialInstrumentAxis__custom--MarketableSecuritiesStockMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zbtXC8AjBkfc" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Total assets measured at fair value">36,735</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--FairValueNetAssetLiability_iI_pp0p0_d0_c20231231__us-gaap--FinancialInstrumentAxis__custom--MarketableSecuritiesStockMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zc0gq1oNDKx2" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Total assets measured at fair value">–</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--FairValueNetAssetLiability_iI_pp0p0_d0_c20231231__us-gaap--FinancialInstrumentAxis__custom--MarketableSecuritiesStockMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z4vx6rG6DK4j" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Total assets measured at fair value">–</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--FairValueNetAssetLiability_iI_pp0p0_c20231231__us-gaap--FinancialInstrumentAxis__custom--MarketableSecuritiesStockMember_zF1M2x2sOS4h" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Total assets measured at fair value">36,735</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Total assets measured at fair value</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--FairValueNetAssetLiability_iI_pp0p0_c20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z6wa0fvF17jb" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets measured at fair value">36,735</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--FairValueNetAssetLiability_iI_pp0p0_d0_c20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zWs7S8SPdIyb" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets measured at fair value">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--FairValueNetAssetLiability_iI_pp0p0_d0_c20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zia9v9m8vqp4" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets measured at fair value">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--FairValueNetAssetLiability_iI_pp0p0_c20231231_zE99cjCdPly8" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets measured at fair value">36,735</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AF_zDed2lNBY73" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The carrying amount of the Company’s financial assets and liabilities, such as cash, accounts receivable, inventories, other receivable, prepaid expenses, deposit, accounts and accrued expenses, payable, treasury stock payable, short-term loan, other current liabilities, customer deposit, approximate their fair value because of the short maturity of those instruments.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
CY2024Q2	us-gaap	Fair Value Net Asset Liability FairValueNetAssetLiability	27580	usd
CY2023Q4	us-gaap	Fair Value Net Asset Liability FairValueNetAssetLiability	36735	usd
CY2024Q2	us-gaap	Revenues Revenues	19753	usd
CY2023Q2	us-gaap	Revenues Revenues	215391	usd
	us-gaap	Revenues Revenues	238911	usd
	us-gaap	Revenues Revenues	451486	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	570124	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	457934	shares
	us-gaap	Net Income Loss NetIncomeLoss	-2680703	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2132409	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-25262873	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-22582170	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1721946	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1606739	usd
CY2024Q2	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	40644	usd
CY2024Q2	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	1051	usd
CY2023Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	1051	usd
CY2024Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	494893	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	281020	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	495944	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	282071	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4930728	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4922318	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	908633	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	841655	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4022095	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4080663	usd
	us-gaap	Depreciation Depreciation	67354	usd
	us-gaap	Depreciation Depreciation	84616	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	56625	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	81069	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	153061	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	201048	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	99570	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	90172	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	31802	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	118517	usd
	FCUV	Operating Lease Weighted Average Remaining Lease Term2 OperatingLeaseWeightedAverageRemainingLeaseTerm2	1.58 to 1.75 years
CY2023	FCUV	Operating Lease Weighted Average Remaining Lease Term2 OperatingLeaseWeightedAverageRemainingLeaseTerm2	2.08 to 2.25 years
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.10	pure
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.10	pure
CY2023Q1	us-gaap	Stock Dividends Shares StockDividendsShares	21592164	shares
CY2023Q2	us-gaap	Stock Dividends Shares StockDividendsShares	21592164	shares
CY2024Q2	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	30000	shares
CY2024Q2	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	48362	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	238911	usd
	us-gaap	Cost Of Revenue CostOfRevenue	251191	usd
	us-gaap	Gross Profit GrossProfit	-12280	usd
	us-gaap	Operating Expenses OperatingExpenses	2686667	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2698947	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	18244	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2680703	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	451486	usd
	us-gaap	Cost Of Revenue CostOfRevenue	330003	usd
	us-gaap	Gross Profit GrossProfit	121483	usd
	us-gaap	Operating Expenses OperatingExpenses	2433943	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2312460	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	180051	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2132409	usd
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
fcuv-20240630_lab.xml	Edgar Link	unprocessable
0001683168-24-005592-index-headers.html	Edgar Link	pending
0001683168-24-005592-index.html	Edgar Link	pending
0001683168-24-005592.txt	Edgar Link	pending
0001683168-24-005592-xbrl.zip	Edgar Link	pending
fcuv-20240630.xsd	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
focus_ex3101.htm	Edgar Link	pending
focus_ex3102.htm	Edgar Link	pending
focus_ex3201.htm	Edgar Link	pending
focus_ex3202.htm	Edgar Link	pending
focus_i10q-063024.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
fcuv-20240630_def.xml	Edgar Link	unprocessable
fcuv-20240630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
focus_i10q-063024_htm.xml	Edgar Link	completed
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
fcuv-20240630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FCUV
FOCUS UNIVERSAL INC. Stock $fcuv

2024 Q3 Form 10-Q Financial Statement

#000168316824005592 Filed on August 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FCUV FOCUS UNIVERSAL INC. Stock $fcuv

2024 Q3 Form 10-Q Financial Statement

#000168316824005592 Filed on August 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FCUV
FOCUS UNIVERSAL INC. Stock $fcuv